HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse

Leukemia

Volumn 15, Issue 1, 2001, Pages 128-133

  Wetzler, M ^a   Baer, M R ^a   Stewart, S J ^a   Donohue, K ^a   Ford, L ^a   Stewart, C C ^a   Repasky, E A ^a   Ferrone, S ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Acute myeloid leukemia; Diagnosis; HLA class I; Relapse

Indexed keywords

CD45 ANTIGEN; HLA ANTIGEN CLASS 1; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; BLAST CELL; BONE MARROW; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CELL INTERACTION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOSURVEILLANCE; LEUKEMIA CELL; LYMPHOCYTE; MALE; MEDICAL LITERATURE; PRESERVATION; PRIORITY JOURNAL; TARGET CELL; TUMOR CELL;

EID: 0035144395     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401982     Document Type: Article

References (22)

1. Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance
2. Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells
3. Loss of surface HLA class I molecules in leukemic myeloblasts is correlated with an increased leukocyte concentration at onset
4. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group
5. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)
6. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy
7. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia
8. 2-m free HLA class I heavy chains
9. Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes
10. Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1
11. Anti-HLA-B7, B27, Bw42, Bw54, Bw55, Bw56, Bw67, Bw73 monoclonal antibodies: Specificity, idiotypes, and application for a double determinant immunoassay
12. Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules
13. Clinical applications of flow cytometry: Immunologic methods for measuring cell membrane and cytoplasmic antigens
14. The use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations
15. T-cell depletion of HLA-identical transplants in leukemia
16. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion
17. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
18. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation